Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo.

Autophagy
Erin E CongdonKaren Duff

Abstract

More than 30 neurodegenerative diseases including Alzheimer disease (AD), frontotemporal lobe dementia (FTD), and some forms of Parkinson disease (PD) are characterized by the accumulation of an aggregated form of the microtubule-binding protein tau in neurites and as intracellular lesions called neurofibrillary tangles. Diseases with abnormal tau as part of the pathology are collectively known as the tauopathies. Methylthioninium chloride, also known as methylene blue (MB), has been shown to reduce tau levels in vitro and in vivo and several different mechanisms of action have been proposed. Herein we demonstrate that autophagy is a novel mechanism by which MB can reduce tau levels. Incubation with nanomolar concentrations of MB was sufficient to significantly reduce levels of tau both in organotypic brain slice cultures from a mouse model of FTD, and in cell models. Concomitantly, MB treatment altered the levels of LC3-II, cathepsin D, BECN1, and p62 suggesting that it was a potent inducer of autophagy. Further analysis of the signaling pathways induced by MB suggested a mode of action similar to rapamycin. Results were recapitulated in a transgenic mouse model of tauopathy administered MB orally at three different doses for ...Continue Reading

References

Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S G Greenberg, P Davies
Oct 1, 1996·Proceedings of the National Academy of Sciences of the United States of America·C M WischikC R Harrington
Jan 24, 2003·Journal of Molecular Neuroscience : MN·Karen DuffYasuji Matsuoka
Jun 24, 2004·Seminars in Cell & Developmental Biology·Yoshinori Ohsumi, Noboru Mizushima
Dec 22, 2004·The Journal of Biological Chemistry·Sayuri TaniguchiMasato Hasegawa
Apr 6, 2006·Proceedings of the National Academy of Sciences of the United States of America·Ashish C MasseyAna Maria Cuervo
Jun 1, 2006·Proceedings of the National Academy of Sciences of the United States of America·Alejandra del C AlonsoKhalid Iqbal
Jun 14, 2006·Proceedings of the National Academy of Sciences of the United States of America·Sylvie Le CorreHanno M Roder
Sep 12, 2006·Neurochemistry International·Ana Flávia FurianLuiz Fernando Freire Royes
Sep 30, 2006·The Journal of Biological Chemistry·Asparouh Iliev IlievFred Silvester Wouters
Feb 6, 2007·Nature Cell Biology·Emilie Vander HaarDo-Hyung Kim
Feb 7, 2007·Journal of Neuropathology and Experimental Neurology·Katy A Chalmers, Seth Love
Mar 17, 2007·Lancet Neurology·Marta Martinez-Vicente, Ana Maria Cuervo
Apr 6, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Zdenek BergerChristopher Janus
Jun 28, 2007·Biochemistry·Mihaela NeculaCharles G Glabe
Sep 25, 2007·Nature Cell Biology·Yoshinori TakahashiHong-Gang Wang
Oct 12, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hani AtamnaBruce N Ames
Nov 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Lihong ZhangJunying Yuan
Feb 26, 2008·The European Journal of Neuroscience·Tadanori HamanoLi-wen Ko
Jun 24, 2008·Nature Reviews. Neuroscience·Jürgen Götz, Lars M Ittner
Oct 10, 2008·Molecular Biology of the Cell·Eisuke ItakuraNoboru Mizushima
Apr 23, 2009·Neurotoxicity Research·Julio C RojasF Gonzalez-Lima
Jul 15, 2009·Neuroscience·J C RojasF Gonzalez-Lima
Oct 2, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Umesh K JinwalChad A Dickey
Oct 30, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Brian SpencerEliezer Masliah
Dec 17, 2009·Brain : a Journal of Neurology·Fiona M MenziesDavid C Rubinsztein
Sep 14, 2010·Proceedings of the National Academy of Sciences of the United States of America·Andrey S TsvetkovSteven Finkbeiner
Apr 2, 2011·The Journal of Biological Chemistry·Yi WenShao-Hua Yang

❮ Previous
Next ❯

Citations

Apr 30, 2013·Molecular Neurobiology·Xi-Chen ZhuLan Tan
Jul 31, 2013·Neuropharmacology·R AnandAbbas Ali Mahdi
May 21, 2013·Lancet Neurology·Maria Grazia Spillantini, Michel Goedert
Mar 15, 2013·Journal of Medicinal Chemistry·Bruno BulicEckhard Mandelkow
Jan 12, 2013·Dementia and Geriatric Cognitive Disorders·Brian S ApplebyJeffrey L Cummings
Dec 18, 2013·Journal of Neuroinflammation·Arnaud FrançoisGuylène Page
Nov 29, 2012·Alzheimer's Research & Therapy·Sharon J Sha, Adam Boxer
Jan 4, 2013·PloS One·Masato HosokawaMasato Hasegawa
Aug 28, 2012·Current Pharmaceutical Design·Victoria A AssimonJason E Gestwicki
Jul 16, 2013·Molecular Neurobiology·Chong WangLan Tan
Oct 10, 2013·Human Molecular Genetics·Hervé TricoireVéronique Monnier
Apr 1, 2014·Cell Communication and Signaling : CCS·Juan A GodoyNibaldo C Inestrosa
Feb 22, 2014·Human Molecular Genetics·Cliona StackMagali Dumont
Feb 28, 2013·The Journal of Biological Chemistry·Alex CroweKurt R Brunden
Feb 13, 2016·Cell Stress & Chaperones·Jürgen Radons
Mar 27, 2013·Progress in Neurobiology·Min Jae LeeDavid C Rubinsztein
Mar 15, 2013·Biochemical and Biophysical Research Communications·Hyun-Wook RyuJunsoo Park
Jul 14, 2012·Pharmacology & Therapeutics·Diana S HimmelsteinLester I Binder
Jan 6, 2016·Drugs·Lidia Bakota, Roland Brandt
Sep 20, 2015·Neurobiology of Disease·Marie VioletMarie-Christine Galas
Apr 5, 2016·Brain Circulation·Zhao Jiang, Timothy Q Duong
Sep 25, 2015·Scientific Reports·Prateep PakavathkumarAndrea C LeBlanc
Jun 2, 2015·Scientific Reports·Sahabudeen Sheik MohideenYuji Yoshiike
Mar 4, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Lawrence I Golbe
Jul 26, 2015·European Journal of Pharmacology·Jaspreet Kalra, Aamir Khan
Mar 30, 2016·Brain : a Journal of Neurology·Tomohiro UmedaTakami Tomiyama
Sep 14, 2015·Molecular Neurobiology·Cheng-Cheng ZhangJin-Tai Yu
Apr 15, 2015·Reviews in the Neurosciences·Ameneh Zare-ShahabadiNima Rezaei
Jul 24, 2012·Biochemical Society Transactions·Yipeng Wang, Eckhard Mandelkow
Apr 23, 2013·Neurobiology of Aging·Teresa Rodríguez-MartínDiane P Hanger
Apr 16, 2016·Future Medicinal Chemistry·Michela RosiniAnna Minarini
May 17, 2014·Molecular Neurobiology·Abhishek Kumar MishraMahendra Pratap Singh
Jul 27, 2014·Ageing Research Reviews·Juha M T HyttinenKai Kaarniranta
Oct 2, 2014·Trends in Pharmacological Sciences·René L VidalClaudio Hetz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Alzheimer's Disease: Endosomes

Dysfunctional endosomal trafficking may be associated with Alzheimer’s disease (AD) pathology. Targeting the endosome may advance treatment options for AD. Here is the latest research on endosomes and AD.

Parkinson's Disease & Autophagy

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy & Aging: Inhibitors

The feed focuses on the role of nuclear export inhibitors and their effect on autophagy and the aging process.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.